JPMorgan Chase & Co. Initiates Coverage on Mobia Medical (NASDAQ:MOBI)

Research analysts at JPMorgan Chase & Co. initiated coverage on shares of Mobia Medical (NASDAQ:MOBI) in a research note issued on Tuesday. The firm set an “overweight” rating and a $15.00 price target on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 11.11% from the stock’s current price.

MOBI has been the subject of several other reports. The Goldman Sachs Group started coverage on Mobia Medical in a research note on Tuesday. They set a “buy” rating and a $31.00 price target for the company. Wall Street Zen upgraded Mobia Medical to a “hold” rating in a report on Saturday, May 16th. Bank of America started coverage on Mobia Medical in a report on Tuesday. They issued a “buy” rating and a $16.00 price objective on the stock. Wolfe Research started coverage on Mobia Medical in a report on Tuesday. They issued an “outperform” rating on the stock. Finally, BTIG Research started coverage on Mobia Medical in a report on Tuesday. They issued a “buy” rating and a $19.00 price objective on the stock. Five equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $20.25.

Mobia Medical Stock Up 3.1%

Shares of NASDAQ:MOBI opened at $13.50 on Tuesday. The firm has a market capitalization of $446.65 million, a PE ratio of 66.00 and a beta of 2.84. Mobia Medical has a 52 week low of $10.19 and a 52 week high of $14.04.

Insider Buying and Selling

In related news, Director Cynthia L. Lucchese bought 125,000 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was bought at an average price of $15.00 per share, with a total value of $1,875,000.00. Following the completion of the transaction, the director directly owned 125,000 shares of the company’s stock, valued at approximately $1,875,000. This represents a ? increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Osage University Gp Iii, Llc bought 533,333 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was bought at an average cost of $15.00 per share, with a total value of $7,999,995.00. Following the transaction, the insider directly owned 2,006,716 shares of the company’s stock, valued at approximately $30,100,740. This trade represents a 36.20% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders have bought 1,268,332 shares of company stock valued at $19,024,980.